Login / Signup

A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Xiao-Lu YuanYi-Peng ZhaoJie HuangJun-Chen LiuWen-Qian MaoJun YinBi-Wen PengWan-Hong LiuSong HanXiao-Hua He
Published in: CNS neuroscience & therapeutics (2018)
ImK prevents neurological damage by suppressing T-cell activation, suggesting the applicability of this peptide in MS therapy.
Keyphrases
  • multiple sclerosis
  • mass spectrometry
  • mouse model
  • signaling pathway
  • ms ms
  • cerebral ischemia
  • magnetic resonance
  • bone marrow
  • mesenchymal stem cells
  • smoking cessation